Latest Regulatory Approval News

Bio-Gene Technology Limited updates on its development of two novel insecticides, Flavocide and Qcide, highlighting regulatory progress, commercial partnerships, and a strong market outlook across multiple sectors.

Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.

Bass Oil Limited reported a 32% jump in October sales revenue alongside a 4% rise in daily production, while advancing its strategic Vanessa gas field acquisition targeting first gas sales in the second half of 2026.

Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in FSGS kidney disease has passed its seventh Independent Data Monitoring Committee review with no safety concerns, reinforcing the drug’s promising safety profile.

Horizon Oil Limited reported robust FY25 results, highlighted by a strategic acquisition of Thailand upstream assets and a 10-year permit extension at Maari, nearly doubling production and securing a strong outlook through 2030.

BCAL Diagnostics is preparing to launch its Avantect® pancreatic and ovarian cancer blood tests in Australia by January 2026, following key regulatory approvals and promising clinical data. The company also broadens the reach of its BREASTESTplus™ breast cancer test, targeting a larger segment of women with dense breast tissue.

Decidr AI Industries has announced a strategic acquisition of Delaware-based Sugarwork Inc., marking its official entry into the US market and enhancing its Agentic AI platform with advanced knowledge transfer capabilities.

Aquirian Limited is accelerating its growth trajectory through strategic joint ventures and a major expansion of its Wubin facility, aiming to reshape the mining services landscape with advanced drill and blast technologies.

Helloworld Travel Limited has made a non-binding indicative all-cash offer to acquire the remaining shares of Webjet Group at A$0.90 per share, signaling a potential major consolidation in the online travel sector.

Li-S Energy has accelerated its transition from research to manufacturing with a $7.8 million ARENA grant, new commercial partnerships, and plans for a large-scale production facility.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

Vintage Energy has signed a conditional agreement to acquire Metgasco's 25% interest in key Southern Flank gas joint ventures, aiming to accelerate production and value creation from the Vali and Odin fields.